Amgen

Vertex Pharmaceuticals

Gilead Sciences

Regeneron Pharmaceuticals

IQVIA Hlds

Illumina

Biogen

Alnylam Pharmaceuticals

ICON

Natera

VanEck Vectors Biotech ETF

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

Horizon Pharma

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

The latest earnings from some of the big biotech players came in at mixed this reporting season.

How Are Biotech ETFs Reacting to Q4 Earnings Releases?

Virtus LifeSci Biotech Products ETF

First Trust NYSE Arca Biotechnology Index Fund

Invesco Dynamic Biotechnology & Genome ETF

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

5 Least-Hurt Biotech ETFs of the Last Week

PHILADELPHIA--( BUSINESS WIRE )--The Private Banking arm of Brown Brothers Harriman & Co. (BBH) is pleased to announce the expansion and strengthening of its Corporate Advisory and Banking team in Philadelphia with the hiring of Dan Vereb. This is reflective of the firm's deep commitment to Philadelphia and the mid-Atlantic region, its private business owners, and to their families.

Brown Brothers Harriman Private Banking Team Expands in Philadelphia

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Clinical Trials ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares Global Healthcare ETF

iShares U.S. Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P SmallCap Health Care ETF

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

ALPS Medical Breakthroughs ETF

Vanguard Health Care ETF

Wisdomtree BioRevolution Fund

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

VanEck Vectors Africa Index ETF

VanEck Vectors Gaming ETF

VanEck Vectors Brazil Small-Cap ETF

VanEck Vectors Social Sentiment ETF

VanEck Vectors ChinaAMC SME-ChiNext ETF

VanEck Vectors Oil Refiners ETF

Vaneck Digital Asset Mining ETF

VanEck Vectors Digital Transformation ETF

Vaneck Digital India ETF

VanEck Vectors Egypt Index ETF

VanEck Video Gaming and eSports ETF

VanEck Vectors Environmental Services ETF 

VanEck Vectors Gold Miners ETF

VanEck Junior Gold Miners ETF

VanEck Green Metals ETF

VanEck Vectors Natural Resource ETF

VanEck Vectors Indonesia Index ETF

VanEck Vectors Israel ETF

VanEck Morningstar Wide Moat ETF

VanEck Vectors Agribusiness ETF

Vaneck Morningstar ESG Moat ETF

VanEck Morningstar Global Wide Moat ETF

VanEck Vectors Morningstar International Moat ETF

VanEck Vectors Uranium+Nuclear Energy ETF

VanEck Vectors Oil Services ETF

VanEck Rare Earth/Strategic Metals ETF

Vaneck Green Infrastructure ETF

VanEck Vectors Russia ETF

VanEck Vectors Russia Small-Cap ETF

VanEck Vectors Retail ETF

VanEck Vectors Steel ETF

VanEck Vectors Semiconductor ETF

VanEck Low Carbon Energy ETF

Vaneck Morningstar SMID Moat ETF

VanEck Vectors Vietnam ETF

VanEck Future of Food ETF

NEW YORK--( BUSINESS WIRE )--VanEck announced today the following 2022 annual distributions per share for its VanEck® equity exchange-traded funds.

VanEck Announces Yearend Distributions for VanEck Equity ETFs

The BBH ETF has an asset base of $520 million, posted strong growth over the past 6 months, and is trading much higher than its pre-pandemic period price range. BMRN, ARGX, ALNY, BIIB, BGNE, GILD, MRNA RGEN, QGEN, and VRTX - 10 stocks constituting 2/3 of the entire BBH portfolio - have registered high double-digit growth.

BBH: Portfolio Of Large-Cap Biotechnology Stocks Has Delivered Strong Returns

There's still plenty of room to run to return to prior highs, but some biotech stocks and exchange traded funds are showing signs of life. That's encouraging after what has been a surprisingly long dour run for biotech assets.

Biotech Finally Getting Its Groove Back

Biotech earnings have come in upbeat in the third quarter.

How Are Biotech ETFs Reacting to Q3 Earnings Releases?

Biotechnology usually isn't the first industry investors think of when it comes to dividends, but some of the more mature companies in the space do deliver payouts. Some of those names reside in the VanEck Vectors Biotech ETF (BBH).

Assessing the Strength of Biotech Dividends With BBH

Chemocentryx

Invesco Dow Jones Industrial Average Dividend ETF

Mirati Therapeutics

Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.

Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth

Eight months into 2022, it's fair to say that it's been a tepid year of deal-making in the biotechnology industry, and that's one reason why the related stocks and exchange traded funds are scuffling.

Consolidation Case for Biotech ETF BBH

ProShares Ultra Nasdaq Biotechnology

iShares Neuroscience And Healthcare ETF

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.

Why Now Could Be The Time To Consider Neuroscience Investments

The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs for Medicare prescriptions at $2,000 per year, starting in 2025.

What The Inflation Reduction Act Means For Drug Prices

he Biotech sector has been in a sweet spot for quite some time now. Plus, earnings releases have also come in mostly upbeat.

How Are Biotech ETFs Reacting to Q2 Earnings Releases?

Following a lengthy wait that included plenty of downside and frustration, biotechnology stocks and exchange traded funds are finding a groove. For example, the VanEck Vectors Biotech ETF (BBH) is higher by 14.23% since the start of the third quarter.

Biotech Bounce-Back Could Be Durable

Global X Cybersecurity ETF

Invesco S&P 500 Equal Weight Technology ETF

The best funds for aggressive investors is our topic for today. An aggressive investing strategy typically seeks returns that are greater than those offered by the broader stock market, such as the S&P 500 index.

3 Best Funds for Aggressive Investors

A long-awaited biotechnology equity rebound could be materializing and some analysts believe it could have the momentum to carry into the end of 2022.

Biotech Rebound Could Finally Be Afoot

Moderna

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its latest quarterly report, along with a share buyback plan. On Wednesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) increased 4.2%, the ETFMG Treatments Testing and Advancements ETF (GERM) advanced 5.

Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs

Owing to its reputation as a growth-heavy industry that's been disappointing investors since early 2021, biotechnology probably isn't the first destination investors think of when seeking shelter-from-the-storm ideas. Look now because the VanEck Vectors Biotech ETF (BBH) jumped 5.15% in July, closing higher by 1.81% last week.

Bank on BBH for Surprising Protection

Biotechnology stocks and the related exchange traded funds are in a prolonged slump, and along the way, calls for rebounds have been plentiful. They've also proven inaccurate.

Biotech Stocks, ETFs Could Be Due for Second Half Rallies

Biotechnology stocks and exchange traded funds are into a second year of disappointing investors, but that condition won't be permanent. With that in mind, investors evaluating ideas for a biotech resurgence may want to consider basic offerings, including the VanEck Vectors Biotech ETF (BBH).

Basic Could Be Beautiful When Biotech Bounces Back

Biotechnology stocks and the related exchange traded funds are under pressure as growth stocks stumble this year, but interested investors have some potential positive facts to ponder. First, biotech valuations are at depressed, rarely seen levels.

Size Up SBIO as Biotech Catalysts Emerge

Since last year, biotechnology stocks and exchange traded funds have been among the most disappointing equity assets, wilting against the backdrop of the coronavirus pandemic and in advance of broader deterioration by growth stocks. Over the past year-plus, it's been common for market observers to ponder exactly when this biotech bear market — which is [.

Betting on Biotech Bear Market Expiration Date

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q1 Earnings Releases?

BBH's price multiples indicate an undervaluation and its major holdings have started recording significant price growth. BBH has strong fundamentals and has performed well enough in the medium and long term.

BBH ETF: Buy This ETF At Discounted Price And Hold It For Long Term

News for VanEck Vectors Biotech ETF ETF (BBH)